Clinical trials
Inflammation trials in Italy with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 6 |
| 2020 | 4 |
| 2021 | 7 |
| 2022 | 7 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Unknown status | 12 |
| Not yet recruiting | 4 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Padova | 5 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 4 |
| University of Bologna | 4 |
| Federico II University | 3 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 3 |
| University of Pavia | 3 |
| Azienda di Servizi alla Persona di Pavia | 2 |
| IRCCS Centro San Giovanni di Dio Fatebenefratelli | 2 |
| Mario Negri Institute for Pharmacological Research | 2 |
| University of Milan | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammation | 51 |
| Obesity | 4 |
| Dysbiosis | 3 |
| COVID-19 | 2 |
| Constipation | 2 |
| Dyslipidemias | 2 |
| Insulin Resistance | 2 |
| Irritable Bowel Syndrome | 2 |
| Metabolic Syndrome | 2 |
| Multiple Sclerosis | 2 |
Trials
Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.